VIVO
Income statement / Annual
Last year (2022), Meridian Bioscience, Inc.'s total revenue was $333.02 M,
an increase of 4.76% from the previous year.
In 2022, Meridian Bioscience, Inc.'s net income was $42.46 M.
See Meridian Bioscience, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
09/30/2015 |
09/30/2014 |
09/30/2013 |
| Operating Revenue |
$333.02 M |
$317.90 M |
$253.67 M |
$201.01 M |
$213.57 M |
$200.77 M |
$196.08 M |
$194.83 M |
$188.83 M |
$188.69 M |
| Cost of Revenue |
$144.66 M
|
$116.75 M
|
$97.42 M
|
$82.69 M
|
$83.11 M
|
$75.94 M
|
$68.30 M
|
$72.95 M
|
$71.59 M
|
$67.64 M
|
| Gross Profit |
$188.36 M
|
$201.15 M
|
$156.25 M
|
$118.33 M
|
$130.46 M
|
$124.83 M
|
$127.79 M
|
$121.88 M
|
$117.24 M
|
$121.04 M
|
| Gross Profit Ratio |
0.57
|
0.63
|
0.62
|
0.59
|
0.61
|
0.62
|
0.65
|
0.63
|
0.62
|
0.64
|
| Research and Development Expenses |
$24.34 M
|
$23.91 M
|
$23.73 M
|
$17.95 M
|
$16.87 M
|
$15.68 M
|
$13.82 M
|
$12.61 M
|
$12.55 M
|
$10.79 M
|
| General & Administrative Expenses |
$57.15 M
|
$52.34 M
|
$46.43 M
|
$34.59 M
|
$34.49 M
|
$33.04 M
|
$30.57 M
|
$27.62 M
|
$27.39 M
|
$30.52 M
|
| Selling & Marketing Expenses |
$31.27 M
|
$26.78 M
|
$26.49 M
|
$28.45 M
|
$34.47 M
|
$32.10 M
|
$29.87 M
|
$25.60 M
|
$24.91 M
|
$22.42 M
|
| Selling, General & Administrative Expenses |
$88.42 M
|
$79.12 M
|
$72.91 M
|
$63.03 M
|
$68.96 M
|
$65.14 M
|
$60.44 M
|
$53.22 M
|
$52.30 M
|
$52.94 M
|
| Other Expenses |
-$350,000.00
|
$4.60 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$112.41 M
|
$107.63 M
|
$96.64 M
|
$80.98 M
|
$85.83 M
|
$80.82 M
|
$74.25 M
|
$65.82 M
|
$64.85 M
|
$63.73 M
|
| Cost And Expenses |
$257.07 M
|
$224.38 M
|
$194.06 M
|
$163.67 M
|
$168.94 M
|
$156.76 M
|
$142.55 M
|
$138.77 M
|
$136.44 M
|
$131.37 M
|
| Interest Income |
$17,000.00
|
$0.00
|
$142,000.00
|
$681,000.00
|
$418,000.00
|
$171,000.00
|
$67,000.00
|
$23,000.00
|
$25,000.00
|
$44,000.00
|
| Interest Expense |
$1.19 M
|
$1.88 M
|
$2.63 M
|
$1.95 M
|
$1.52 M
|
$1.64 M
|
$897,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$16.51 M
|
$15.29 M
|
$13.57 M
|
$9.96 M
|
$7.92 M
|
$8.12 M
|
$6.63 M
|
$5.22 M
|
$5.56 M
|
$5.62 M
|
| EBITDA |
$72.02 M |
$107.62 M |
$75.49 M |
$43.47 M |
$39.82 M |
$46.19 M |
$58.17 M |
$60.28 M |
$52.39 M |
$62.99 M |
| EBITDA Ratio |
0.22
|
0.34
|
0.3
|
0.22
|
0.19
|
0.23
|
0.3
|
0.31
|
0.31
|
0.33
|
| Operating Income Ratio |
0.17
|
0.29
|
0.24
|
0.16
|
0.15
|
0.19
|
0.26
|
0.29
|
0.28
|
0.3
|
| Total Other Income/Expenses Net |
-$1.19 M
|
-$2.58 M
|
-$2.03 M
|
-$1.14 M
|
-$1.20 M
|
-$953,000.00
|
-$734,000.00
|
-$997,000.00
|
-$284,000.00
|
$48,000.00
|
| Income Before Tax |
$54.32 M
|
$90.45 M
|
$59.29 M
|
$31.56 M
|
$30.38 M
|
$36.43 M
|
$50.64 M
|
$55.06 M
|
$52.11 M
|
$57.36 M
|
| Income Before Tax Ratio |
0.16
|
0.28
|
0.23
|
0.16
|
0.14
|
0.18
|
0.26
|
0.28
|
0.28
|
0.3
|
| Income Tax Expense |
$11.86 M
|
$19.04 M
|
$13.11 M
|
$7.18 M
|
$6.53 M
|
$14.87 M
|
$18.42 M
|
$19.52 M
|
$17.37 M
|
$19.33 M
|
| Net Income |
$42.46 M
|
$71.41 M
|
$46.19 M
|
$24.38 M
|
$23.85 M
|
$21.56 M
|
$32.23 M
|
$35.54 M
|
$34.74 M
|
$38.03 M
|
| Net Income Ratio |
0.13
|
0.22
|
0.18
|
0.12
|
0.11
|
0.11
|
0.16
|
0.18
|
0.18
|
0.2
|
| EPS |
0.96 |
1.62 |
1.07 |
0.57 |
0.56 |
0.51 |
0.77 |
0.85 |
0.84 |
0.92 |
| EPS Diluted |
0.96 |
1.62 |
1.07 |
0.57 |
0.56 |
0.51 |
0.76 |
0.85 |
0.83 |
0.91 |
| Weighted Average Shares Out |
$44.01 M
|
$44.01 M
|
$43.17 M
|
$42.90 M
|
$42.75 M
|
$42.19 M
|
$42.01 M
|
$41.66 M
|
$41.46 M
|
$41.23 M
|
| Weighted Average Shares Out Diluted |
$44.01 M
|
$44.01 M
|
$43.17 M
|
$42.90 M
|
$42.75 M
|
$42.57 M
|
$42.39 M
|
$42.01 M
|
$41.91 M
|
$41.90 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
